nonmem version 7.3.0 (ICON plc)
90
Structured Review
ICON plc
nonmem version 7.3.0
Nonmem Version 7.3.0, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonmem+version+7%2E3%2E0/nonmem+version+7+3/pm40613748-103-13-16
Average 90 stars, based on 1 article reviews
Nonmem Version 7.3.0, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonmem+version+7%2E3%2E0/nonmem+version+7+3/pm40613748-103-13-16
Average 90 stars, based on 1 article reviews
nonmem version 7.3.0 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: An exposure‐response analysis of ponesimod clinical efficacy in a randomized phase III study in patients with relapsing multiple sclerosis Article Snippet: Data analysis was performed using Article Title: Precision Dosing in Presence of Multiobjective Therapies by Integrating Reinforcement Learning and PK-PD Models: Application to Givinostat Treatment of Polycythemia Vera. Article Snippet: Residual Unexplained Variability (RUV) was not considered in simulations, assuming the status evolution of the PV patient was fully described by its PK- PD model. NONMEM Article Title: Model-Informed Dosing Regimen of Ticagrelor in Chinese Patients With Acute Coronary Syndrome. Article Snippet: The basic Article Title: Precision Dosing in Presence of Multiobjective Therapies by Integrating Reinforcement Learning and PK ‐ PD Models: Application to Givinostat Treatment of Polycythemia Vera Article Snippet: Residual Unexplained Variability (RUV) was not considered in simulations, assuming the status evolution of the PV patient was fully described by its PK‐PD model. NONMEM Article Title: Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma. Article Snippet: Non- linear mixed effects modeling for the population PK analysis was performed using Article Title: POPULATION PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS ON DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME Article Snippet: The population pharmacokinetic (PK) analysis of pantoprazole was conducted through nonlinear mixed-effects modeling (NONMEM (RRID:SCR_016986), Article Title: Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease Article Snippet: The analyses were performed using Article Title: In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients Article Snippet: The PK/PD model was identified in |